Successful HLA-identical hematopoietic stem cell transplantation in a patient with purine nucleoside phosphorylase deficiency

Pediatric Transplantation

Volumn 11, Issue 7, 2007, Pages 799-803

  Delicou, Sophia ^a,b   Kitra Roussou, Vassiliki ^b   Peristeri, Julia ^b   Goussetis, Eugenios ^b   Vessalas, George ^b   Rigatou, Eftymia ^b   Psychou, Fotini ^b   Salavoura, Katerina ^b   Grafakos, Stelios ^b  

^a St Sophia Children's Hospital ^*  (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Hematopoietic stem cell transplantation; Purine nucleoside phosphorylase deficiency; Refractory hemolytic anemia

Indexed keywords

AZATHIOPRINE; BUSULFAN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; RITUXIMAB; TACROLIMUS; THYMOCYTE ANTIBODY;

ANAMNESIS; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; ENZYME DEFICIENCY; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA SYSTEM; HUMAN; HUMAN TISSUE; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LOW DRUG DOSE; MALE; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROPHYLAXIS; PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY;

ANEMIA; BIOPSY; CHILD, PRESCHOOL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA ANTIGENS; HUMANS; MALE; PURINE-NUCLEOSIDE PHOSPHORYLASE; SIBLINGS; TISSUE DONORS; TRANSPLANTATION CHIMERA; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME;

EID: 34848889052     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00772.x     Document Type: Article

References (23)

1. Nyhan WL. Disorders of purine and pyrimidine metabolism. Mol Genet Metab 2005 : 86 : 25 33.
2. Fleischman A, Hershfield MS, Toutain S, et al. Adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency in common variable immunodeficiency. Clin Diagn Lab Immunol 1998 : 5 : 399 400.
3. Aust MR, Andrews LG, Barrett MJ, et al. Molecular analysis of mutations in a patient with purine nucleoside phosphorylase deficiency. Am J Hum Genet 1992 : 51 : 763 772.
4. Markert ML, Finkel BD, Mc Laughlin TM, et al. Mutations in PNP deficiency. Hum Mutat 1997 : 9 : 118 121.
5. Markert ML. Purine nucleoside phosphorylase deficiency. Immunodef Rev 1991 : 3 : 45 81.
6. Fisher A, Cavazzana-Calvo M, De Saint Basile G, et al. Naturally occurring primary deficiencies of the immune system. Annu Rev Immunol 1997 : 15 : 93 124.
7. Carlson DA, Wasson DB, Lakow E, et al. Possible metabolic basis for the different immunodefecient states associated with genetic deficiencies of ADA and PNP. Proc Natl Acad Sci USA 1992 : 79 : 3848 3852.
8. Wilson JM, Mitchel BS, Daddova PE, et al. Purinogenic immunodeficiency diseases. J Clin Invest 1979 : 64 : 1475 1484.
9. Mitchell BS, Mejias E, Daddona PE, et al. Purinogenic immunodeficiency diseases: Selective toxicity of deoxyribonucleosides for T Cells. Proc Natl Acad Sci USA 1978 : 75 : 5011 5014.
10. Arpaia E, Bebveniste P, Cristofano ADI, et al. Mitochondrial basis for immune deficiency: Evidence from purine nucleoside phosphorylase-deficient mice. J Exp Med 2000 : 191 : 2197 2208.
11. Tabarki B, Yacoub M, Tlili K, et al. Familial spastic paraplegia as the presenting manifestation in patients with purine nucleoside phosphorylase deficiency. J Child Neurol 2003 : 18 : 140 141.
12. Nowak-Wegrzyn A, King Karen E, Shirey RS, et al. Fatal warm autoimmune hemolytic anemia resulting from IgM autoagglutinins in an infant with severe combined immunodeficiency. J Pediatr Hematol Oncol 2001 : 23 : 250 252.
13. Yigal D, Eyal G, Johann H, et al. Purine nucleoside phosphorylase deficiency associated with a dysplastic marrow morphology. Pediatr Res 2004 : 55 : 472 477.
14. Kleijer WJ, Hussaarts-Odijk LM, Los FJ, et al. Prenatal diagnosis of purine nucleoside phosphorylase deficiency in the first and second trimesters of pregnancy. Prenat Diagn 1989 : 9 : 401 407.
15. Staal GE, Stoop JW, Zegers BJ, et al. Erythrocyte metabolism in purine nucleoside phosphorylase deficiency after enzyme replacement therapy by infusion of erythrocytes. J Clin Invest 1980 : 65 : 103 108.
16. Carpenter PA, Ziegler JB, Vowels MR. Late diagnosis and correction of purine nucleoside phosphorylase deficiency with allogeneic bone marrow transplantation. Bone Marrow Transplant 1996 : 17 : 121 124.
17. Classen CF, Schultz AS, Sigl-Kraetziq M, et al. Successful HLA-identical bone marrow transplantation in a patient with PNP deficiency using busulfan and fludarabine for conditioning. Bone Marrow Transplant 2001 : 28 : 93 96.
18. Rovelli AM, Steward CG. Hematopoietic cell transplantation activity in Europe for inherited metabolic diseases: Open issues and future directions. Bone Marrow Transplant 2005 : 35 (Suppl. 1 S23 S26.
19. Broome CB, Graham ML, Saulsbury FT, et al. Correction of purine nucleoside phosphorylase deficiency by transplantation of allogeneic bone marrow from a sibling. J Pediatr 1996 : 128 : 373 376.
20. Good RA, Verjee T. Historical and current perspectives on bone marrow transplantation for prevention and treatment of immunodeficiencies and autoimmunities. Biol Blood Marrow Transplant 2001 : 7 : 123 135.
21. Morecki S, Gelfand Y, Nagler A, et al. Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen. Bone Marrow Transplant 2001 : 28 : 243 249.
22. Marmont AM. Immune ablation and stem cell transplantation for severe Evans syndrome and refractory thrombocytopenic porpura. Bone Marrow Transplant 1999 : 23 : 1215 1216.
23. Steward C. Stem cell transplantation for non-malignant disorders. Best Pract Res Clin Haematol 2000 : 13 : 343 363.